Curis
CRIS
#10633
Rank
โ‚ฌ10.98 M
Marketcap
0,28ย โ‚ฌ
Share price
55.98%
Change (1 day)
-84.77%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -โ‚ฌ29.24 Million

According to Curis's latest financial reports the company's current earnings are โ‚ฌ11.65 Million. In 2024 the company made an earning of -โ‚ฌ37.56 Million, an increase over its 2023 earnings that were of -โ‚ฌ39.86 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ29.24 Million-22.16%
2024 -โ‚ฌ37.56 Million-5.77%
2023 -โ‚ฌ39.86 Million-13.1%
2022 -โ‚ฌ45.87 Million27.52%
2021 -โ‚ฌ35.97 Million65.09%
2020 -โ‚ฌ21.79 Million-9.1%
2019 -โ‚ฌ23.97 Million-4.73%
2018 -โ‚ฌ25.16 Million-41.95%
2017 -โ‚ฌ43.34 Million-14.37%
2016 -โ‚ฌ50.61 Million3.55%
2015 -โ‚ฌ48.87 Million271.52%
2014 -โ‚ฌ13.16 Million76.64%
2013 -โ‚ฌ7.45 Million
2011 -โ‚ฌ6.33 Million27.76%
2010 -โ‚ฌ4.95 Million-43.87%
2009 -โ‚ฌ8.82 Million-23.44%
2008 -โ‚ฌ11.52 Million56.66%
2007 -โ‚ฌ7.36 Million-16.71%
2006 -โ‚ฌ8.83 Million-36.92%
2005 -โ‚ฌ14 Million156.25%
2004 -โ‚ฌ5.47 Million-37.24%
2003 -โ‚ฌ8.71 Million-93.34%
2002 -โ‚ฌ0.14 Billion86.79%
2001 -โ‚ฌ69.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ9.29 B-32,629.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.42 B-29,576.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚ฌ54.34 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚ฌ0.88 B-3,181.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.26 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚ฌ21.75 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.14 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA